Ysios Capital Partners takes part in Kala Pharmaceuticals' closing of $68 Million Series C Financing

by Ysios Capital

Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering, and is backed by leading life sciences investors including Longitude Capital, OrbiMed, Vivo Capital, CAM Ca...

Read more
Subscribe to Directory
Write an Article

Highlight

3i closes second European CLO, Harvest V...

by 3i Group

3i Group plc (“3i” or “3i Group”), an international investor, ...

Inveready Convertible Finance realiza su...

by Inveready

Inveready se une así a una compañía de alto crecimiento liderando l...

Photos Stream